Abstract
Tachycardia-induced cardiomyopathy (TIC) is considered a reversible form of left ventricular dysfunction. Although patients with TIC are at high risk of sudden cardiac arrest, once the heart rate is under control rapid clinical improvement is expected. Hence, an implantable defibrillator (ICD) may not be an optimal clinical solution before a permanent risk is identified. Moreover, the tachycardia burden (usually of supraventricular origin) makes TIC patients more susceptible to false shocks. Previous studies have reported the effectiveness of a wearable cardioverter defibrillator (WCD) in terminating life-threatening ventricular arrhythmias (VAs).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
